Clinical Trial

Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Indies

Study acronym: DiAGeNA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Genetics variants could be involved in atypical non-autoimmune diabetes revealed by ketoacidosis. The objective of this research will be to determine the relationships between the genetic variants already described in known monogenic diabetes or identified as involved in glucose metabolism and its regulation, in insulin signaling pathways or in insulin secretion itself in subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.
Trial Details
NCT Number NCT07576374
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions Metabolic Diseases, Diabetes Mellitus (Type 2), Genetic Variation, Genetic Profile, Glucose Metabolism Disorders
Enrollment 118 participants
Start Date 2026-06
Primary Completion 2029-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-08